Dear Colleagues,

One of the biggest challenges associated with the aging population is dementia. The World Alzheimer reported that the number of people living with dementia could triple to 132 million worldwide by 2050. Dementia, particularly Alzheimer’s disease (AD), is a growing pandemic that presents profound challenges to healthcare systems, families, and societies worldwide. Brain aging is associated with patterns of functional and structural changes. To reduce the risk of dementia in the future, there is an immediate need for interventions that target the disease process from its earliest stages. Research programs are increasingly focusing on midlife as a critical period for the beginning of AD-related pathology. However, early disease process indicators in asymptomatic individuals are still poorly understood. In this Special Issue, we welcome reviews, short communications, and original research articles highlighting the molecular and cellular mechanisms and therapeutic strategies for brain aging and dementia. All articles submitted to this Issue should be original, never previously published in any journal, or presented at a conference. Submitted papers should meet the internationally accepted criteria and manuscripts should follow the journal style for both reviewing and editing.

Dr. Nasrollah Moradikor
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. NeuroSci is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.